Reasons for delay and coexisting diagnoses in patients with decompensation of pre-existing diabetes
| Characteristics | Overall, N=420* | Year 1 (2019–2020), N=244* | Year 2 (2020–2021), N=176* |
| Delays in presentation† | |||
| No delay documented | 409 (97) | 238 (98) | 171 (97) |
| Delay in getting GP appointment | 0 (0) | 0 (0) | 0 (0) |
| Delay in GP referral to hospital | 1 (0.2) | 1 (0.4) | 0 (0) |
| General COVID-related advice to stay at home, no consultation with primary care (GP, 111 or equivalent) | 1 (0.2) | 0 (0) | 1 (0.6) |
| Advised to stay at home as outcome of primary care consultation (GP, 111 or equivalent), either COVID or non-COVID-related | 0 (0) | 0 (0) | 0 (0) |
| Parent/child concerns over visiting hospital, non-COVID related | 0 (0) | 0 (0) | 0 (0) |
| Parent/child concerns over visiting hospital, related to COVID exposure | 0 (0) | 0 (0) | 0 (0) |
| Other | 9 (2.1) | 5 (2.0) | 4 (2.3) |
| Coexisting diagnoses† | |||
| Asthma/wheeze | 1 (0.2) | 1 (0.) | 0 (0) |
| Infection | 66 (16) | 47 (19) | 19 (11) |
| Mental health crisis | 10 (2.4) | 5 (2.0) | 5 (2.8) |
| Trauma | 0 (0) | 0 (0) | 0 (0) |
| Other | 7 (1.7) | 3 (1.2) | 4 (2.3) |
| None of the above | 337 (80) | 188 (77) | 149 (85) |
| Contributing factors† | |||
| Patient compliance with treatment | 144 (34) | 80 (33) | 64 (36) |
| Availability/supply of therapeutic treatment | 11 (2.6) | 6 (2.5) | 5 (2.8) |
| Travel (eg, left drug at home) | 5 (1.2) | 2 (0.8) | 3 (1.7) |
| Family-related issues | 38 (9.0) | 17 (7.0) | 21 (12) |
| Equipment failure | 39 (9.3) | 17 (7.0) | 22 (12) |
| Other | 22 (5.2) | 12 (4.9) | 10 (5.7) |
| None | 215 (51) | 130 (53) | 85 (48) |
*n (%).
†Tick all that apply.
GP, general practitioner.